References
- Ginés P, Quintero E, Arroyo V, Tértis J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122–8.
- Arroyo V, Rodés J. A rational approach to the treatment of ascites. Postgrad Med J 1975;51:558–62.
- Brunner G, Bergmann K, Hacker W, Mollendorff E. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. Arzneimittelforschung/ Drug Res 1988;38(1):176–9.
- Broekhuysen J, Deger F, Douchamps J, Ducarne H, Herchuelz A. Torasemide, a new potent diuretic. Double-blind comparison with furosemide. Eur J Clin Pharmacol 1986;31 Suppl:29–34.
- Lambe R, Kennedy O, Kenny M, Darragh A. Study of the tolerance and diuretic properties of torasemide following oral or intravenous administration to healthy volunteers. Eur J Clin Pharmacol 1986;31 Suppl:9–14.
- Laffi G, Marra F, Buzzelli G, Azzena G, Meacci E, De Feo M, et al. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study. Hepatology 1991;13:1101–5.
- Applefeld J, Kasmer R, Hak L, Dukes G, Wermeling D, McClain C. A dose-response study of orally administered torsemide in patients with ascites due to cirrhosis. Aliment Pharmacol Ther 1994;8(4):397–402.
- Gerbes A, Bertheau-Reitha U, Falkner C, Jungst D, Paumgartner G. Advantages of the new loop diuretic torasemide over furosemide in patients with cirrhosis and ascites. A randomized, double-blind cross-over trial. J Hepatol 1993;17:353–8.
- Gentilini P, Laffi G, La Villa G, Carloni V, Foschi M, Romanelli R, et al. Torasemide in the treatment of patients with cirrhosis and ascites. Cardiovasc Drugs Ther 1993;7 Suppl 1:81–7.
- Zanazzi M, Ratti G, Ballocchi S, Scarpioni L. Torasemide vs. furosemide in cirrhosis. In: Puschett JB, Greenberg A, editors. Diuretic III: chemistry, pharmacology, and clinical applications. Amsterdam: Elsevier; 1990. p. 399–401.
- Fiaccadori F, Pedretti G, Pasetti P, Pizzaferri G, Elia G. Torasemide versus furosemide in cirrhosis: a long-term, doubleblind, randomized clinical study. Clin Investig 71;1993:579–84.
- Uchida T, Hayashi K, Suzuki Y, Matsumura Y. Effects of torasemide on renal haemodynamics and function in anesthetized dogs. Clin Pharmacol Physiol 1991;18:497.
- Blose JS, Adams KF, Patterson JH. Torasemide: a pyridine-sulfonylurea loop diuretic. Ann Pharmacother 1995;29(4):396–402.
- Goodfriend T, Ball D, Oelkers W, Bahr V. Torsemide inhibits aldosterone secretion in vitro. Life Sci 1998;63(3):45–50.
- Uchida T, Yamanagua K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M. Anti-aldosteronergic effect of torasemide. Eur J Pharmacol 1991;205:145–50.
- Elia G, Ferrari C, Degli Antoni A, Penna A, Fiaccadori F. A short-term clinical study of a new loop diuretic, torasemide, in cirrhosis. Ital J Gastroenterol 1989;21:324–8.
- Marelli A, Bodini P, Reggiani M, Quinzani M, Dizioli P, Tonghini L. Confronto tra torasemide e furosemide nella terapia dell’ascite in pazienti cirrotici. Minerva Med 1997;88:109–15.
- Keller E, Hoppe-Seyler G, Mumm R, Schollmeyer P. Influence of hepatic cirrhosis and end-stage renal disease on pharmacokinetics and pharmacodynamics of furosemide. Eur J Clin Pharmacol 1981;20:27–33.
- Pockros P, Reynolds T. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema. Gastroenterology 1986;90:1827–33.
- Schwartz S, Brater D, Pound D, Green P, Kramer W, Rudy D. Bioavailability, pharmacokinetics and pharmacodynamics of torasemide in patients with cirrhosis. Clin Pharmacol Ther 1993;54(1):90–7.